Life Sciences
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
Cough-monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.
RxPass, which will be available to Prime members, will offer generic drugs for common conditions like high blood pressure and anxiety.
The companies will link their data capabilities to provide life science firms insight into social risk drivers.
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
The home diagnostics company also cut 170 manufacturing jobs in the summer.